Clinical Trial Update: Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the optimal duration of oxaliplatin in adjuvant XELOX for gastric cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Gastric Cancer | Phase 3 | Status: RECRUITING